{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:00:25Z","timestamp":1789002025972,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to assess the adherence to monitoring guidelines regarding amiodarone treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective cohort study of data recorded in Clalit Health Services, the largest healthcare organization in Israel. Included were individuals aged &amp;gt;18 years; who were prescribed amiodarone and had a documented purchase of this drug, for a minimum of 200 consecutive days; and who had less than a 100-day gap between two consecutive purchases during 2013\u20132021. Adherence was assessed to testing for thyroid, liver function, and electrolytes, as determined by the performance of a test every 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 24,094 individuals (mean age: 75 years, 53% male). The median follow-up was 2.3 years (total 73,727 person-years). The proportions of patients who performed baseline tests were: 43.4% for thyroid function, 58.3% for electrolytes, 48.6% for liver function, 20.6% for chest X-rays, and 14.9% for electrocardiograms. Adherence rates to semiannual monitoring of thyroid function, liver function, and electrolyte tests were: 70.4%, 79.4%, and 88.3%, respectively. In a multivariable analysis, the factors associated with higher adherence were male sex; older age; the presence of thyroid abnormalities, renal failure, and hypertension; and more frequent visits to the primary care physician.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our country, adherence is low to monitoring risk factors for adverse effects of amiodarone therapy, especially prior to treatment initiation. Patient and primary care physicians should be educated about the importance of monitoring, particularly prior to initiation of amiodarone treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1408799","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T05:05:28Z","timestamp":1720155928000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Adherence to monitoring of patients treated with amiodarone: a nationwide study"],"prefix":"10.3389","volume":"11","author":[{"given":"Amit","family":"Frenkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Smadar Shneyour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Shiloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Shimoni-Rachmilev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Dreiher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.18773\/austprescr.2019.051","article-title":"Amiodarone in the elderly","volume":"42","author":"Srinivasan","year":"2019","journal-title":"Aust Prescriber."},{"key":"B2","doi-asserted-by":"publisher","first-page":"104167","DOI":"10.1016\/j.amsu.2022.104167","article-title":"Clinical Profile and Side Effects of chronic use of oral Amiodarone in cardiology outpatients department (CLIPSE-A Study)- a prospective observational study","volume":"80","author":"Fatima","year":"2022","journal-title":"Ann Med Surg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S3799","DOI":"10.21037\/jtd.2018.09.144","article-title":"A review and analysis of strategies for prediction, prevention and management of post-operative atrial fibrillation after non-cardiac thoracic surgery","volume":"10","author":"Smith","year":"2018","journal-title":"J Thorac Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1053\/j.jvca.2020.10.060","article-title":"Acute amiodarone pulmonary toxicity","volume":"35","author":"Feduska","year":"2021","journal-title":"J Cardiothorac Vasc Anesth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.amjmed.2007.04.022","article-title":"Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation","volume":"120","author":"Batcher","year":"2007","journal-title":"Am J Med."},{"key":"B6","first-page":"11","article-title":"How toxic is amiodarone to the liver?","volume":"19","author":"Pollak","year":"2010","journal-title":"J Gastrointestin Liver Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.amjmed.2015.08.039","article-title":"Practical management guide for clinicians who treat patients with amiodarone","volume":"129","author":"Epstein","year":"2016","journal-title":"Am J Med."},{"key":"B8","unstructured":"Amiodarone monitoring protocol2018"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone. Practice guidelines subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","author":"Goldschlager","year":"2000","journal-title":"Arch Intern Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40545-020-00235-1","article-title":"Compliance with the North American Society of Pacing and Electrophysiology guidelines on amiodarone monitoring in Riyadh, Saudi Arabia: a retrospective chart review study","volume":"13","author":"Albassam","year":"2020","journal-title":"J Pharmaceutical Policy Pract."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2333392819844635","article-title":"Adherence to monitoring guidelines of amiodarone adverse reactions","volume":"6","author":"Lavon","year":"2019","journal-title":"Health Serv Res Manag Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.clinthera.2009.06.014","article-title":"Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review","volume":"31","author":"Snider","year":"2009","journal-title":"Clin Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/0897190017729523","article-title":"Frequency of adverse events monitoring in ambulatory patients on amiodarone or dofetilide","volume":"31","author":"Rickard","year":"2018","journal-title":"J Pharm Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1345\/aph.1Q158","article-title":"Baseline and follow-up laboratory monitoring of cardiovascular medications","volume":"45","author":"Tjia","year":"2011","journal-title":"Ann Pharmacother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1445-5994.2006.01068.x","article-title":"Monitoring the use of amiodarone: compliance with guidelines","volume":"36","author":"Burgess","year":"2006","journal-title":"Int Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12258","DOI":"10.1111\/1755-5922.12258","article-title":"Population-level incidence and monitoring of adverse drug reactions with long-term amiodarone therapy","volume":"35","author":"Rankin","year":"2016","journal-title":"Cardiovasc Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jep.12619","article-title":"Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction","volume":"23","author":"Huang","year":"2017","journal-title":"J Eval Clin Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0897190009358770","article-title":"Adherence to amiodarone monitoring recommedations before and after implementation of a centralized pharmacy service: a cohort study","volume":"23","author":"Johnson","year":"2010","journal-title":"J Pharm Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1001\/archinte.165.20.2395","article-title":"Improving laboratory monitoring at initiation of drug therapy in ambulatory care: a randomized trial","volume":"165","author":"Raebel","year":"2005","journal-title":"Arch Int Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1016\/S0140-6736(17)30876-0","article-title":"Digital health nation: Israel's global big data innovation hub","volume":"389","author":"Balicer","year":"2017","journal-title":"Lancet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S2213-8587(17)30372-8","article-title":"Using big data for non-communicable disease surveillance","volume":"6","author":"Balicer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1408799\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T05:05:32Z","timestamp":1720155932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1408799\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":21,"alternative-id":["10.3389\/fmed.2024.1408799"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1408799","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"article-number":"1408799"}}